• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

速激肽NK1和NK2受体中神经肽介导的激活机制的分子决定因素。

Molecular determinants of neuropeptide-mediated activation mechanisms in tachykinin NK1 and NK2 receptors.

作者信息

Petersen Jacob E, Pavlovskyi Artem, Madsen Jesper J, Schwartz Thue W, Frimurer Thomas M, Olsen Ole H

机构信息

Section for Metabolic Receptology, Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark.

Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA; Center for Global Health and Infectious Diseases Research, Global and Planetary Health, College of Public Health, University of South Florida, Tampa, Florida, USA.

出版信息

J Biol Chem. 2024 Dec;300(12):107948. doi: 10.1016/j.jbc.2024.107948. Epub 2024 Oct 30.

DOI:10.1016/j.jbc.2024.107948
PMID:39481599
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11625327/
Abstract

Substance P and neurokinin A are closely related neuropeptides belonging to the tachykinin family. Their receptors are neurokinin one receptor (NK1R) and neurokinin two receptor (NK2R), G protein-coupled receptors that transmit G and G-mediated downstream signaling. We investigate the importance of sequence differences at the bottom of the receptor orthosteric site for activity and selectivity, focusing on residues that closely interact with the C-terminal methionine of the peptide ligands. We identify a conserved serine (NK1R-S297) and the position of the tryptophan residue within the canonical "toggle switch" motif, CWxP of TM6, neighboring a phenylalanine in NK1R (NK1R-F264) and a tyrosine in NK2R (NK2R-Y266), giving rise to distinct microenvironments for the neuropeptide C terminals. Mutating these residues results in dramatic activity changes in both NK1R and NK2R due to a close interaction between the ligand and toggle switch. Structural analysis of active and inactive NKR structures suggests only a minor change in sidechain rotation of toggle switch residues upon activation. However, extensive molecular dynamics simulations of receptor:neuropeptide:G protein complexes indicate that a major, concerted motion happens in the toggle switch tryptophan indole group and the sidechains of the microswitch motif Pro-Ile-Phe (PIF). This rotation establishes a tight hydrogen bond interaction from the tryptophan indole to the conserved serine (NK1R-S297) and a mainchain carbonyl (NK1R-A294) in the kink of TM7. This interaction facilitates communication with the NPxxY microswitch motif of TM7, resulting in stabilization of the G protein-binding region. NK1R-S297 is consequently identified as a central hub for the activation of NKRs.

摘要

P物质和神经激肽A是属于速激肽家族的密切相关的神经肽。它们的受体是神经激肽1受体(NK1R)和神经激肽2受体(NK2R),这两种受体是G蛋白偶联受体,可传递G和G介导的下游信号。我们研究了受体正构位点底部的序列差异对活性和选择性的重要性,重点关注与肽配体C末端甲硫氨酸紧密相互作用的残基。我们确定了一个保守的丝氨酸(NK1R-S297)以及典型的“切换开关”基序(TM6的CWxP)中色氨酸残基的位置,该位置与NK1R中的苯丙氨酸(NK1R-F264)和NK2R中的酪氨酸(NK2R-Y266)相邻,从而为神经肽C末端形成了不同的微环境。由于配体与切换开关之间的紧密相互作用,突变这些残基会导致NK1R和NK2R的活性发生显著变化。对活性和非活性NKR结构的结构分析表明,激活后切换开关残基的侧链旋转仅有微小变化。然而,受体:神经肽:G蛋白复合物的广泛分子动力学模拟表明,切换开关色氨酸吲哚基团和微开关基序Pro-Ile-Phe(PIF)的侧链发生了主要的协同运动。这种旋转建立了从色氨酸吲哚到保守丝氨酸(NK1R-S297)和TM7扭结中的主链羰基(NK1R-A294)的紧密氢键相互作用。这种相互作用促进了与TM7的NPxxY微开关基序的通讯,从而稳定了G蛋白结合区域。因此,NK1R-S297被确定为NKR激活的中心枢纽。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2792/11625327/6a38e0abef9b/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2792/11625327/d14a0ed659bb/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2792/11625327/e206f0ded5c7/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2792/11625327/8e4bce636207/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2792/11625327/38cfd40d6db1/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2792/11625327/614e8a8f01d0/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2792/11625327/f6cbb427d350/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2792/11625327/6a38e0abef9b/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2792/11625327/d14a0ed659bb/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2792/11625327/e206f0ded5c7/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2792/11625327/8e4bce636207/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2792/11625327/38cfd40d6db1/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2792/11625327/614e8a8f01d0/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2792/11625327/f6cbb427d350/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2792/11625327/6a38e0abef9b/gr7.jpg

相似文献

1
Molecular determinants of neuropeptide-mediated activation mechanisms in tachykinin NK1 and NK2 receptors.速激肽NK1和NK2受体中神经肽介导的激活机制的分子决定因素。
J Biol Chem. 2024 Dec;300(12):107948. doi: 10.1016/j.jbc.2024.107948. Epub 2024 Oct 30.
2
Deciphering specificity and cross-reactivity in tachykinin NK1 and NK2 receptors.解析速激肽NK1和NK2受体的特异性与交叉反应性。
J Biol Chem. 2023 Dec;299(12):105438. doi: 10.1016/j.jbc.2023.105438. Epub 2023 Nov 7.
3
Challenging activity and signaling bias in tachykinin NK1 and NK2 receptors by truncated neuropeptides.截短神经肽对速激肽NK1和NK2受体的挑战性活性及信号偏向性
J Biol Chem. 2025 Jun;301(6):108522. doi: 10.1016/j.jbc.2025.108522. Epub 2025 Apr 19.
4
Differential consequences of neurokinin receptor 1 and 2 antagonists in metastatic breast carcinoma cells; Effects independent of Substance P.神经激肽受体1和2拮抗剂在转移性乳腺癌细胞中的不同作用;与P物质无关的效应
Biomed Pharmacother. 2018 Dec;108:263-270. doi: 10.1016/j.biopha.2018.09.013. Epub 2018 Sep 14.
5
Characterization of species-related differences in the pharmacology of tachykinin NK receptors 1, 2 and 3.速激肽NK受体1、2和3药理学中物种相关差异的特征分析
Biochem Pharmacol. 2009 May 1;77(9):1522-30. doi: 10.1016/j.bcp.2009.01.020. Epub 2009 Feb 6.
6
Tachykinin Receptor-Selectivity of the Potential Glioblastoma-Targeted Therapy, DOTA-[Thi,Met(O)]-Substance P.潜在神经胶质瘤靶向治疗药物 DOTA-[Thi,Met(O)]-Substance P 的速激肽受体选择性。
Int J Mol Sci. 2023 Jan 21;24(3):2134. doi: 10.3390/ijms24032134.
7
Effects of intravenous administration of neurokinin receptor subtype-selective agonists on gonadotropin-releasing hormone pulse generator activity and luteinizing hormone secretion in goats.静脉注射神经激肽受体亚型选择性激动剂对山羊促性腺激素释放激素脉冲发生器活性和促黄体生成素分泌的影响。
J Reprod Dev. 2015;61(1):20-9. doi: 10.1262/jrd.2014-109. Epub 2014 Oct 27.
8
Binding epitopes for peptide and non-peptide ligands on the NK1 (substance P) receptor.NK1(P物质)受体上肽和非肽配体的结合表位
Regul Pept. 1993 Jul 2;46(1-2):49-58. doi: 10.1016/0167-0115(93)90011-v.
9
Altered expression of the tachykinins substance P/neurokinin A/hemokinin-1 and their preferred neurokinin 1/neurokinin 2 receptors in uterine leiomyomata.速激肽P物质/神经激肽A/血红蛋白-1及其首选的神经激肽1/神经激肽2受体在子宫平滑肌瘤中的表达改变。
Fertil Steril. 2016 Nov;106(6):1521-1529. doi: 10.1016/j.fertnstert.2016.07.007. Epub 2016 Jul 25.
10
Substance P and neurokinin 1 receptor boost the pathogenicity of granulocyte-macrophage colony-stimulating factor-producing T helper cells in dry eye disease.P物质和神经激肽1受体增强了干眼症中产生粒细胞-巨噬细胞集落刺激因子的辅助性T细胞的致病性。
Scand J Immunol. 2025 Jan;101(1):e13434. doi: 10.1111/sji.13434.

本文引用的文献

1
Deciphering specificity and cross-reactivity in tachykinin NK1 and NK2 receptors.解析速激肽NK1和NK2受体的特异性与交叉反应性。
J Biol Chem. 2023 Dec;299(12):105438. doi: 10.1016/j.jbc.2023.105438. Epub 2023 Nov 7.
2
Structural insights into neurokinin 3 receptor activation by endogenous and analogue peptide agonists.内源性和类似物肽激动剂激活神经激肽3受体的结构洞察
Cell Discov. 2023 Jun 30;9(1):66. doi: 10.1038/s41421-023-00564-w.
3
Neurokinin 3 receptor antagonist-induced adipocyte activation improves obesity and metabolism in PCOS-like mice.
神经激肽 3 受体拮抗剂诱导脂肪细胞激活可改善多囊卵巢综合征样小鼠的肥胖和代谢。
Life Sci. 2022 Dec 1;310:121078. doi: 10.1016/j.lfs.2022.121078. Epub 2022 Oct 14.
4
Mechanistic basis of GPCR activation explored by ensemble refinement of crystallographic structures.通过晶体结构的总体精修探索 G 蛋白偶联受体激活的机制基础。
Protein Sci. 2022 Nov;31(11):e4456. doi: 10.1002/pro.4456.
5
Structural insights into the activation of neurokinin 2 receptor by neurokinin A.神经激肽A激活神经激肽2受体的结构见解
Cell Discov. 2022 Jul 26;8(1):72. doi: 10.1038/s41421-022-00437-8.
6
Modulating the tachykinin: Role of substance P and neurokinin receptor expression in ocular surface disorders.调节速激肽:P 物质和神经激肽受体表达在眼表疾病中的作用。
Ocul Surf. 2022 Jul;25:142-153. doi: 10.1016/j.jtos.2022.06.007. Epub 2022 Jun 30.
7
ColabFold: making protein folding accessible to all.ColabFold:让蛋白质折叠变得人人可用。
Nat Methods. 2022 Jun;19(6):679-682. doi: 10.1038/s41592-022-01488-1. Epub 2022 May 30.
8
Structures of neurokinin 1 receptor in complex with G and G proteins reveal substance P binding mode and unique activation features.神经激肽1受体与G蛋白和G蛋白复合物的结构揭示了P物质的结合模式和独特的激活特征。
Sci Adv. 2021 Dec 10;7(50):eabk2872. doi: 10.1126/sciadv.abk2872. Epub 2021 Dec 8.
9
Selective G protein signaling driven by substance P-neurokinin receptor dynamics.由 P 物质神经激肽受体动力学驱动的选择性 G 蛋白信号转导。
Nat Chem Biol. 2022 Jan;18(1):109-115. doi: 10.1038/s41589-021-00890-8. Epub 2021 Oct 28.
10
Highly accurate protein structure prediction with AlphaFold.利用 AlphaFold 进行高精度蛋白质结构预测。
Nature. 2021 Aug;596(7873):583-589. doi: 10.1038/s41586-021-03819-2. Epub 2021 Jul 15.